Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A22707 | 24366230 | Curr Opin Lipidol | Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field. | 2014 | Details |
A22710 | 24365277 | Med Hypotheses | Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients. | 2013 | Details |
A22716 | 24361070 | Nutr Metab Cardiovasc Dis | Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis. | 2013 | Details |
A22744 | 24336007 | Med Sci Monit | Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes. | 2013 | Details |
A22771 | 24320032 | Curr Pharm Des | The metabolic syndrome and chronic liver disease. | 2014 | Details |
A22772 | 24317388 | Blood Coagul Fibrinolysis | Changes in the levels of endothelium-derived coagulation parameters in nonalcoholic fatty liver disease. | 2014 | Details |
A22785 | 24304731 | Rev Invest Clin | [Decrease of liver fat content by aerobic exercise or metformin therapy in overweight or obese women]. | 2014 | Details |
A22790 | 24303090 | World J Hepatol | Association between nonalcoholic fatty liver disease and acute ischemic stroke severity and outcome. | 2013 | Details |
A22793 | 24300906 | Eur J Clin Nutr | Body composition and body fat distribution are related to cardiac autonomic control in non-alcoholic fatty liver disease patients. | 2013 | Details |
A22798 | 24297186 | Rev Endocr Metab Disord | Adiponectin signaling in the liver. | 2014 | Details |
A22812 | 26202293 | Hepatol Int | Hard clinical outcomes in patients with NAFLD. | 2013 | Details |
A22821 | 24285955 | Int J Endocrinol | Multidisciplinary approach to the treatment of obese adolescents: effects on cardiovascular risk factors, inflammatory profile, and neuroendocrine regulation of energy balance. | 2013 | Details |
A22826 | 24280560 | Med Hypotheses | Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction. | 2013 | Details |
A22833 | 24275089 | Food Chem Toxicol | Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. | 2013 | Details |
A22837 | 24274877 | Clin Liver Dis | The interactions of nonalcoholic fatty liver disease and cardiovascular diseases. | 2013 | Details |
A22842 | 24274870 | Clin Liver Dis | The impact of obesity and metabolic syndrome on chronic hepatitis C. | 2013 | Details |
A22853 | 24251710 | J Gastroenterol Hepatol | Role of diet and nutritional management in non-alcoholic fatty liver disease. | 2013 | Details |
A22855 | 24251708 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease: factors associated with its presence and onset. | 2013 | Details |
A22857 | 24251706 | J Gastroenterol Hepatol | Diet and exercise in management of obesity and overweight. | 2013 | Details |
A22858 | 24251704 | J Gastroenterol Hepatol | Obesity and gastrointestinal liver disorders in Japan. | 2013 | Details |
A22863 | 24268461 | Arch Gerontol Geriatr | Diastolic dysfunction and cardiovascular risk in old subjects: possible association with NAFLD? | 2013 | Details |
A22871 | 24264040 | Int J Mol Sci | Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment. | 2013 | Details |
A22879 | 24259612 | Ann Pharmacother | Resistant nonalcoholic fatty liver disease amelioration with rosuvastatin and pioglitazone combination therapy in a patient with metabolic syndrome. | 2013 | Details |
A22902 | 24222944 | World J Gastroenterol | Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease. | 2013 | Details |
A22904 | 24222095 | Semin Liver Dis | Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease. | 2013 | Details |
A22918 | 24211299 | Gastroenterology | Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease. | 2013 | Details |
A22924 | 24206551 | Rev Esp Enferm Dig | Pathogenesis, diagnosis and treatment of non-alcoholic fatty liver disease. | 2013 | Details |
A22926 | 24205731 | Nihon Rinsho | [An inhibitor of intestinal cholesterol transporter]. | 2013 | Details |
A22930 | 24198448 | J Saudi Heart Assoc | Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events. | 2013 | Details |
A22963 | 30736139 | Expert Rev Endocrinol Metab | Current management of patients with nonalcoholic fatty liver disease. | 2013 | Details |
A22970 | 24159791 | Klin Med (Mosk) | [Additional advantages of mexicor used in combined therapy of coronary heat disease and diabetes mellitus of 2nd type]. | 2013 | Details |
A22973 | 24152749 | Nutrients | Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). | 2013 | Details |
A22977 | 24150574 | Aging Clin Exp Res | Adipocyte-fatty acid binding protein and non-alcoholic fatty liver disease in the elderly. | 2013 | Details |
A22987 | 24133663 | Clin Mol Hepatol | Elevated red cell distribution width is associated with advanced fibrosis in NAFLD. | 2013 | Details |
A22997 | 24127654 | Curr Med Res Opin | Are statins 'IDEAL' for non-alcoholic fatty liver disease? | 2013 | Details |
A23003 | 24119987 | Nutr Metab Cardiovasc Dis | Early left ventricular abnormality/dysfunction in obese children affected by NAFLD. | 2013 | Details |
A23010 | 24118857 | Liver Int | Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease. | 2013 | Details |
A23014 | 24115757 | Obesity (Silver Spring) | Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects. | 2013 | Details |
A23018 | 24114821 | Ann Hepatol | Metabolic syndrome and nonalcoholic fatty liver disease. The role of endothelial progenitor cells. | 2014 | Details |
A23021 | 24113587 | Int J Mol Sci | Role of hepatic progenitor cells in nonalcoholic fatty liver disease development: cellular cross-talks and molecular networks. | 2013 | Details |
A23029 | 24098813 | PLoS One | Fatty liver is associated with transcriptional downregulation of stearoyl-CoA desaturase and impaired protein dimerization. | 2013 | Details |
A23030 | 24098525 | PLoS One | Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis. | 2013 | Details |
A23034 | 24090729 | Clin Gastroenterol Hepatol | Evidence and recommendations for imaging liver fat in children, based on systematic review. | 2013 | Details |
A23042 | 24083161 | Indian J Endocrinol Metab | Emerging risk factors for cardiovascular diseases: Indian context. | 2013 | Details |
A23050 | 24076414 | Clin Gastroenterol Hepatol | Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis. | 2013 | Details |
A23052 | 24075754 | Atherosclerosis | A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? | 2013 | Details |
A23057 | 28839736 | Frontline Gastroenterol | Piloting a multidisciplinary clinic for the management of non-alcoholic fatty liver disease: initial 5-year experience. | 2013 | Details |
A23060 | 24072087 | J Clin Res Pediatr Endocrinol | Relationship between aspartate aminotransferase-to-platelet ratio index and carotid intima-media thickness in obese adolescents with non-alcoholic fatty liver disease. | 2013 | Details |
A23090 | 24047563 | Endocr J | The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels. | 2013 | Details |
A23094 | 24044579 | Lipids Health Dis | Age-dependent effect of high-fructose and high-fat diets on lipid metabolism and lipid accumulation in liver and kidney of rats. | 2013 | Details |
A23100 | 24040875 | Curr Pharm Des | The role of statins in the treatment of type 2 diabetes mellitus: an update. | 2014 | Details |
A23121 | 24025980 | Eur J Gastroenterol Hepatol | High red blood cell distribution width is closely associated with nonalcoholic fatty liver disease. | 2014 | Details |
A23123 | 24023483 | World J Gastroenterol | What does irritable bowel syndrome share with non-alcoholic fatty liver disease? | 2013 | Details |
A23137 | 24010102 | Pediatr Gastroenterol Hepatol Nutr | Gut microbiota and clinical disease: obesity and nonalcoholic Fatty liver disease. | 2013 | Details |
A23151 | 24002776 | Hepatology | Extrahepatic complications of nonalcoholic fatty liver disease. | 2014 | Details |
A23153 | 24000796 | Free Radic Res | Oxysterols and redox signaling in the pathogenesis of non-alcoholic fatty liver disease. | 2013 | Details |
A23158 | 23997501 | J Clin Exp Hepatol | Serum γ-glutamyltranspeptidase predicts all-cause, cardiovascular and liver mortality in older adults. | 2013 | Details |
A23170 | 23985808 | Am J Clin Nutr | Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism. | 2013 | Details |
A23172 | 23974690 | Indian J Dermatol Venereol Leprol | Comorbidities in psoriasis. | 2013 | Details |
A23181 | 23981342 | Cardiovasc Diabetol | Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease. | 2013 | Details |
A23182 | 23981121 | J Gastroenterol Hepatol | Increased whole blood viscosity associated with arterial stiffness in patients with non-alcoholic fatty liver disease. | 2014 | Details |
A23187 | 23976771 | JPEN J Parenter Enteral Nutr | The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD). | 2013 | Details |
A23192 | 23973920 | Gastroenterology | Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis. | 2013 | Details |
A23199 | 23966104 | Thromb Haemost | The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome. | 2013 | Details |
A23203 | 23962548 | Clin Gastroenterol Hepatol | Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease. | 2013 | Details |
A23220 | 23945039 | Eur J Prev Cardiol | Gamma-glutamyltransferase, insulin resistance and cardiometabolic risk profile in a middle-aged African population. | 2013 | Details |
A23221 | 23944954 | Liver Int | Hepatic steatosis in diabetic patients does not predict adverse liver-related or cardiovascular outcomes. | 2013 | Details |
A23225 | 23940240 | Pediatrics | Ethnic differences in the link between insulin resistance and elevated ALT. | 2013 | Details |
A23226 | 23940130 | J Clin Pathol | Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. | 2013 | Details |
A23228 | 23939604 | Am Fam Physician | Nonalcoholic fatty liver disease: diagnosis and management. | 2013 | Details |
A23251 | 23924883 | Int J Environ Res Public Health | Relationship between retinal vascular caliber and coronary artery disease in patients with non-alcoholic fatty liver disease (NAFLD). | 2013 | Details |
A23272 | 23913408 | Hepatology | Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. | 2013 | Details |
A23283 | 23898557 | Acta Gastroenterol Belg | Treatment of non-alcoholic fatty liver disease: can we already face the epidemic? | 2013 | Details |
A23287 | 23897104 | Ann Clin Biochem | Plasma adiponectin is a more specific marker of fatty liver than a marker of metabolic syndrome in Japanese men. | 2013 | Details |
A23291 | 23895155 | Am J Chin Med | Ligusticum chuanxiong prevents ovariectomy-induced liver and vascular damage in rats. | 2013 | Details |
A23297 | 23889731 | Expert Opin Investig Drugs | Statins and nonalcoholic fatty liver disease: a bright future? | 2013 | Details |
A23306 | 23879722 | Curr Med Res Opin | Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review. | 2013 | Details |
A23310 | 23875703 | Clin Sci (Lond) | Involvement of the HIF-1α and Wnt/β-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia/reperfusion injury. | 2014 | Details |
A23311 | 23855304 | J Gastroenterol Hepatol | Family with sequence similarity 3 gene family and nonalcoholic fatty liver disease. | 2013 | Details |
A23322 | 23871755 | Free Radic Biol Med | MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases. | 2013 | Details |
A23342 | 23858556 | Hepatogastroenterology | Blood urea nitrogen is elevated in patients with non-alcoholic fatty liver disease. | 2013 | Details |
A23346 | 23853345 | Orv Hetil | [Non-alcoholic fatty liver disease and steatohepatitis]. | 2013 | Details |
A23353 | 23848366 | Expert Opin Emerg Drugs | Emerging drugs for non-alcoholic steatohepatitis. | 2013 | Details |
A23354 | 23847661 | Arch Med Sci | Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study. | 2013 | Details |
A23357 | 23844815 | Curr Pharm Des | Nonalcoholic fatty liver disease and cardiovascular disease. | 2014 | Details |
A23368 | 23840139 | World J Gastroenterol | Exposure to ambient air particulate matter and non-alcoholic fatty liver disease. | 2013 | Details |
A23372 | 23837080 | Australas Med J | Primary non-alcoholic fatty liver disease in hypertensive patients. | 2013 | Details |
A23374 | 23834773 | BMC Gastroenterol | Fatty liver index correlates with non-alcoholic fatty liver disease, but not with newly diagnosed coronary artery atherosclerotic disease in Chinese patients. | 2013 | Details |
A23383 | 23829707 | Ups J Med Sci | Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis. | 2013 | Details |
A23387 | 23826984 | Clin Sci (Lond) | Endothelial dysfunction in hyperandrogenic polycystic ovary syndrome is not explained by either obesity or ectopic fat deposition. | 2014 | Details |
A23388 | 23826593 | Aust Fam Physician | Fatty liver disease--a practical guide for GPs. | 2013 | Details |
A23408 | 23805974 | Biochem J | Brown adipose tissue: development, metabolism and beyond. | 2013 | Details |
A23423 | 23796801 | Gene | Associations of the PTEN -9C>G polymorphism with insulin sensitivity and central obesity in Chinese. | 2013 | Details |
A23427 | 23793849 | Curr Hypertens Rep | Fructose-containing sugars, blood pressure, and cardiometabolic risk: a critical review. | 2013 | Details |
A23428 | 23792440 | Pol Arch Med Wewn | Relationship between ultrasound features of nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes. | 2013 | Details |
A23432 | 23791233 | J Pediatr (Rio J) | Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents. | 2013 | Details |
A23451 | 23770180 | J Am Coll Cardiol | Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. | 2013 | Details |
A23463 | 23758436 | Clin Sci (Lond) | Impact of PPAR-α induction on glucose homoeostasis in alcohol-fed mice. | 2013 | Details |
A23470 | 23751754 | J Hepatol | From NAFLD in clinical practice to answers from guidelines. | 2013 | Details |
A23475 | 23746214 | Clin Endocrinol (Oxf) | A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver disease. | 2013 | Details |